Cas No.: 2027476-29-3
PRODUCT INFORMATION
Description
VSLRGDTRG is a synthetic RGD-containing peptide derived from cadherin 17 (CDH17) that binds α2β1 integrin. This binding stimulates its conformational activation, leading to enhanced β1 integrin affinity, FAK/ERK1/2 phosphorylation, and subsequent signaling in CDH17-expressing cell lines. This mechanism involves a CDH17-specific RGD-integrin interaction, which is studied for its role in coordinating dual ligand engagement with collagen IV.
Molecular Weight
960.05
Purity
> 95%
Formula
C₃₈H₆₉N₁₅O₁₄
Product Type
Targeting Peptide
Sequence
Val-Ser-Leu-Arg-Gly-Asp-Thr-Arg-Gly
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- Cyclo(RADfK) Targeting Peptide (CAT#: OLY-1025-YS-61)
- Cyclo(Arg-Ala-Asp-(D-Tyr)-Lys) Targeting Peptide (CAT#: OLY-1025-YS-36)
- Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA Targeting Peptide (CAT#: OLY-1025-YS-68)
- Somatostatin-28 (1-14) Targeting Peptide (CAT#: OLY-1025-YS-60)
- LSD Targeting Peptide (CAT#: OLY-1025-YS-2)
- Breast Cancer Targeting Peptide 18-4 (CAT#: OLY-1025-YS-23)
- GPLGLAGGWGERDGS Targeting Peptide (CAT#: OLY-1025-YS-25)
- Cyclo(-RGDfK) TFA Targeting Peptide (CAT#: OLY-1025-YS-53)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.